- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16.01. | AbbVie's Skyrizi takes full-year TV ad spending crown yet again, with J&J's Tremfya in hot pursuit | ||
| 15.01. | Trump takes aim at insurance industry, drug prices in unveiling 'The Great Healthcare Plan' | ||
| 15.01. | FDA tells Sanofi, GSK, AstraZeneca and CSL to include warnings for febrile seizures on flu shot labels | ||
| 15.01. | FDA chides BeOne, ImmunityBio promo materials in first untitled letters of 2026 | ||
| 15.01. | JPM26: Astellas CEO resists 'rescue BD' as $6B Xtandi patent cliff nears | ||
| 15.01. | After succeeding in combo with Darzalex, J&J's Tecvayli shines as solo act | ||
| 15.01. | Hologic sets a screen to block cervical cancer with WNBA's Erica Wheeler | ||
| 15.01. | BD budgets $110M to expand Nebraska syringe production | ||
| 14.01. | JPM26: Jazz's $200M voucher sale shows drumbeat of rising prices isn't stopping | ||
| 14.01. | Bayer taps Gabrielle Union-Wade as face of menopause med Lynkuet | ||
| 14.01. | Lenz ups Vizz visibility with DTC campaign starring Sarah Jessica Parker | ||
| 14.01. | Amneal and VantAI unveil fresh branding to kick off 2026 plans | ||
| 14.01. | FDA delays decision on Travere's Filspari in key kidney disease indication | ||
| 14.01. | JPM26: Novo Nordisk CEO reflects on 'curse of a leader' as company looks to reassert GLP-1 footing | ||
| 13.01. | JPM26: Ionis, bolstered by strong launch of Tryngolza, doubles its sales projection in new indication to $2B | ||
| 13.01. | JPM26: Leo Pharma, hungry for more partnerships, looks to widen reach in rare dermatology diseases | ||
| 13.01. | FDA blesses Sentynl and Cyprium's Zycubo as 1st treatment for Menkes disease | ||
| 13.01. | AbbVie inks latest White House drug pricing deal, scoring tariff reprieve as it makes $100B US investment pledge | ||
| 12.01. | JPM26: Bristol Myers CEO to 'cast a broad net' as business development remains a top priority | ||
| 12.01. | Cellares to expand cell therapy factory-in-a-box to Europe with new Netherlands facility | ||
| 12.01. | JPM26: Apellis shares tumble with sales decline for eye disease treatment Syfovre | ||
| 12.01. | Atara, Pierre Fabre allege FDA about-face as agency hands down 2nd Ebvallo snub | ||
| 12.01. | Bristol Myers Squibb paves way for expansion of Camzyos to adolescent patients | ||
| 12.01. | AbbVie drops $175M on Ariz. drug-device plant as US investment tour rolls on | ||
| 09.01. | Putting patients first: from buzzword to business imperative |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.